Frequency Therapeutics Inc

NASDAQ:FREQ   3:59:57 PM EDT
7.54
+0.03 (+0.40%)
Earnings Announcements

Frequency Therapeutics - Expects Existing Cash, Cash Equivalents, Marketable Securities To Be Sufficient To Fund Operations Into 2023

Published: 08/12/2021 11:46 GMT
Frequency Therapeutics Inc (FREQ) - Frequency Therapeutics - Expects Existing Cash, Cash Equivalents, Marketable Securities to Be Sufficient to Fund Operations Into 2023.
Qtrly Revenue $9.4 Million Versus $8.5 Million.
Qtrly Loss per Share $0.52.
Q2 Earnings per Share View $-0.51, Revenue View $6.7 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $2.38 Million
Adjusted EPS is expected to be -$0.57

Next Quarter Revenue Guidance is expected to be $32.32 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.